BioCircuit Technologies specializes in innovative solutions for nerve repair, prominently featuring their flagship product, Nerve Tape®. This device is the first FDA-cleared sutureless connector designed to facilitate the repair of transected peripheral nerves. Nerve Tape® utilizes a combination of porcine small intestinal submucosa and nitinol microhooks, allowing for a self-adhering wrap that simplifies the repair process. The open wrap design ensures precise alignment of the nerve ends, minimizes tissue adhesions, and protects the repair site, ultimately preventing axonal escape. Clinical studies have demonstrated that Nerve Tape® significantly reduces repair time and enhances repair strength compared to traditional microsuture methods, making it a promising advancement in the field of neuromodulation and neural interfacing.

The clinical evidence supporting Nerve Tape® highlights its efficiency and effectiveness, with repairs being completed up to 4.8 times faster than conventional microsutures. Additionally, the tensile strength of repairs using Nerve Tape® is reported to be 2.6 times greater, providing a robust solution for nerve discontinuities. This technology is particularly beneficial for larger nerves, where the time savings and strength advantages are even more pronounced. BioCircuit Technologies aims to improve patient outcomes in nerve repair through these advanced methodologies, positioning Nerve Tape® as a leading option in surgical practices.

United States

BioCircuit is a medical device company that specializes in advanced solutions for tissue repair and neuromodulation, highlighted by their innovative product, Nerve Tape®, the first sutureless device for repairing transected nerves.

BioCircuit Technologies

Company Details